Furthermore, therapeutic agents, including the histone deacetylase inhibitor LBH589 and the natural compound β-elemene, modulate cancer cell migration and invasion by regulating the MTA3–Snail–E-cadherin axis (12, 31). The gene discussed is SNAI1; the disease is cancer.